Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells

Che-Yi Lin; Pei-Ling Hsieh; Yi-Wen Liao; Chih-Yu Peng; Ming-Yi Lu; Ching-Hsuan Yang; Cheng-Chia Yu; Chia-Ming Liu

doi:10.18632/oncotarget.25460

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells

PDF | How to cite

Oncotarget. 2018; 9:24870-24870. https://doi.org/10.18632/oncotarget.25460

Metrics: PDF 1601 views | ?

Che-Yi Lin¹, Pei-Ling Hsieh^2,*, Yi-Wen Liao^3,*, Chih-Yu Peng³, Ming-Yi Lu³, Ching-Hsuan Yang², Cheng-Chia Yu^2,3,4 and Chia-Ming Liu^3,4

¹Department of Oral and Maxillofacial Surgery, Chi Mei Hospital, Tainan, Taiwan
²Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan
³School of Dentistry, Chung Shan Medical University, Taichung, Taiwan
⁴Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan
^*These authors have contributed equally to this work

Published: May 15, 2018

This article has been corrected: The correct 4th affiliation is given below:

⁴Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan

Original article: Oncotarget. 2017; 8:80900-80908. DOI: https://doi.org/10.18632/oncotarget.20723.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25460

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells